(DecisionDx®-Melanoma, TissueCypher®) increased 37% over 2024 Exceeded 2025 guidance with full-year revenue of $344 million ...
Full Year 2025 Highlights Revenue increased 17% to a record €1,290 millionGenerated profit for the period of €100 million, 7.8% as a percentage of revenueAdjusted EBITDA1 increased 33% to a record ...
GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," "GoodRx," or the "Company"), the leading platform for medication savings in the U.S., has released its financial results for the fourth quarter ...
Koppers Holdings Inc. (NYSE: KOP), an integrated global provider of treated wood products, wood treatment chemicals, and carbon compounds, today reported its fourth quarter and full-year 2025 results.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results